Registered entities
ADAMAS PHARMACEUTICALS, INC.
Reg. No. 421560076United States
Innovation
9 patent families (5 granted) — focus: Human necessities; filing pace slowing. Cited 6,329 times.
| Year | Filings |
|---|---|
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
Social engagement
Social engagement: 25.8K social following, 5 posts in the last 12 months — around the industry typical range.
Investor mix
11 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 55% |
| Private equity | 2 | 18% |
| Accelerator & incubator | 1 | 9% |
| Other / undisclosed | 2 | 18% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
19 Mar 2026 · clinical research study evaluating an investigational drug for the treatment of Attention-Deficit/Hyperactivit
Based on job postings tracked across public sources.
Recent activity
12 Jun 2026
Recognition
7 Apr 2026
Event
AMCP conference